SNPHY (SNPHY) Stock Price & Analysis
SNPHY (SNPHY) rose 0.26% to USD 11.65 as of July 25, 2026 at 13:06 UTC, according to Nexqual real-time market data.
SNPHY last closed at USD 11.62; the session ranged USD 12.29–12.34 on volume of 170 shares. Market capitalization is $3.75B, with a 52-week range of USD 9.22–13.93 (PNK). Source: Nexqual, July 25, 2026 at 13:06 UTC.
Key Statistics (as of July 25, 2026 at 13:06 UTC)
| Price | USD 11.65 |
|---|---|
| Change | ▲ 0.26% (up) |
| Previous Close | USD 11.62 |
| Open | USD 12.34 |
| Day Range | USD 12.29 – 12.34 |
| 52-Week Range | USD 9.22 – 13.93 |
| Volume | 170 shares |
| Market Cap | $3.75B |
| Exchange | PNK |
Technical Analysis (SNPHY)
Nexqual's technical model rates SNPHY "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 13:06 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 40.2 (neutral) |
| vs SMA50 | Below (USD 12.43) |
| MACD | -0.1 (negative) |
Analyst Ratings (SNPHY)
Wall Street analysts rate SNPHY "None", per Nexqual as of July 25, 2026 at 13:06 UTC.
| Consensus Rating | None |
|---|
Earnings (SNPHY)
| Revenue Estimate | $70.47B |
|---|
Source: Nexqual, July 25, 2026 at 13:06 UTC.
Financials & Fundamentals (SNPHY)
| Total Revenue | $291.62B |
|---|---|
| Revenue Growth (YoY) | +4.70% |
| Gross Margin | +58.21% |
| Operating Margin | +22.27% |
| Profit Margin | +12.81% |
| ROE | +12.93% |
| Debt / Equity | 11.74 |
| Current Ratio | 2.6 |
| Total Cash | $80.88B |
| Total Debt | $34.75B |
| Free Cash Flow | $17.27B |
Source: Nexqual, July 25, 2026 at 13:06 UTC.
Financial Health Score (SNPHY)
Nexqual rates SNPHY's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 13:06 UTC.
| Growth | Strong — Revenue +55% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 58%, operating 22% |
| Balance Sheet | Strong — $80.9B cash vs $34.8B debt, net cash position |
| Cash Flow | Solid — FCF $17.3B, 6% margin |
| Efficiency | Mixed — ROE 13%, ROA 6.9% |
Ownership (SNPHY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 321.69M |
| Float | 301.47M |
Source: Nexqual, July 25, 2026 at 13:06 UTC.
Leadership (SNPHY)
SNPHY is led by Takeshi Ito (age 66), President, CEO & Representative Director, per Nexqual as of July 25, 2026 at 13:06 UTC.
| President, CEO & Representative Director | Takeshi Ito (age 66) |
|---|---|
| CFO & Corporate Officer | Kazuo Koshiji |
Major Backers & Investors (SNPHY)
Notable institutional backers of SNPHY include WisdomTree Trust-WisdomTree Japan Hedged Equity Fund, according to Nexqual as of July 25, 2026 at 13:06 UTC.
Active Investors
| Investor | Stake |
|---|---|
| WisdomTree Trust-WisdomTree Japan Hedged Equity Fund | 0.14% |
Source: Nexqual, July 25, 2026 at 13:06 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OPHLY | Ono Pharmaceutical Co., Ltd. | USD 4.93 | ▲ 1.65% |
| OTSKY | Otsuka Holdings Co. Ltd. | USD 34.02 | ▲ 1.12% |
| SGIOY | Shionogi & Co. Ltd. | USD 8.68 | ▼ 0.8% |
| SSMXY | Sysmex Corp. | USD 9.29 | ▼ 1.9% |
| RYKKY | Ryohin Keikaku Co. Ltd. | USD 13.75 | ▲ 0.36% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:06 UTC. This page is informational and not investment advice.